DigestRedComo funciona
Red
/
Empresas
Ja
No verificado

Jaguar Gene Therapy, LLC

Sobre qué escribimos

BiotecnologíaIndustriaMedicina - VariosSaludSanidad

2 Comunicados de prensa

Ver todos los comunicados de prensa
24/02/2026
Industria
Salud
Biotecnología
Sanidad
Medicina - Varios
Jaguar Gene Therapy Announces Successful Completion of Dosing of First Patient Cohort in Clinical Trial Evaluating JAG201 for the Treatment of a Leading Monogenic Cause of Autism Spectrum Disorder Known as Phelan-McDermid Syndrome
Fuente
Jaguar Gene Therapy, LLC
Editor
Business Wire
1.00
0
09/07/2024
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Sanidad
Farmacéutica
Salud
Jaguar Gene Therapy to Initiate Inaugural Pediatric Clinical Trial Targeting a Genetic Form of Autism Spectrum Disorder and Phelan-McDermid Syndrome
Fuente
Jaguar Gene Therapy, LLC
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0